Services on Demand
Article
Indicators
Related links
- Cited by SciELO
- Similars in SciELO
Bookmark
Revista médica (Cochabamba)
Print version ISSN 2074-4609
Abstract
MENDEZ DELGADILLO, Litzy M.; PARDO NOVAK, Antonio and URIONA ARCE, Remy R.. LEVELS OF MAGNESEMIA IN THE MANAGEMENT OF PREGNANT WOMEN WITH SEVERE PRE-ECLAMPSIA TREATED WITH MAGNESIUM SULPHATE. Rev. méd. (Cochabamba) [online]. 2010, vol.21, n.1, pp. 39-45. ISSN 2074-4609.
Severe preclampsia is a pathology that affects 3% of the pregnant women hospitalized in our hospital and its correct management is highly valuable for the high risk of morbi mortality that represents for the mother - child binomial. The present study was made in a group of pregnant women with severe preclampsia that were treated at Maternoinfantil Germán Urquidi hospital and who received magnesium sulphate as treatment, with doses according protocols of the SUMI. The dosis were controlled with levels of magnesemia to determine the reached therapeutic ranks. We concluded that none of the patients of this study, reached magnesium therapeutic levels, with interrupted a magnesium sulphate administration in the service of dilatantes to 2-6 hrs de initiated in treatment; the patients did not present clinical manifestations of intoxication by magnesium and most of them had a conserved renal function. Many of the patients were between the 16 - 25 years, attending his first gestation, with pregnancies majors to 34 weeks in predominant form. We recommend to modify the administration protocols of magnesium sulphate to 6gr./ charge dose and 2gr. /hr maintenance infusion, with laboratory controls to control the reached therapeutic ranks in each patient.
Keywords : Magnesium sulphate; severe preeclampsia; levels of magnesemia.